Sheila M. Grant
Chief Tech/Sci/R&D Officer en XENON PHARMACEUTICALS INC. .
Perfil
Sheila M.
Grant is currently the Executive VP-Research & Development Operations at Xenon Pharmaceuticals, Inc. Prior to her current position, she served as the Chief Operating Officer at Correvio Pharma Corp.
from 2013 to 2020.
Additionally, she worked as a Consultant at Twinstrand Therapeutics, Inc. Ms. Grant holds an MBA from Simon Fraser University, a graduate degree from the London School of Hygiene & Tropical Medicine, and an undergraduate degree from the University of Essex.
Cargos activos de Sheila M. Grant
| Empresas | Cargo | Inicio |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
Antiguos cargos conocidos de Sheila M. Grant.
| Empresas | Cargo | Fin |
|---|---|---|
| CORREVIO PHARMA CORP. | Chief Operating Officer | 27/05/2020 |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Corporate Officer/Principal | - |
Formación de Sheila M. Grant.
| Simon Fraser University | Masters Business Admin |
| London School of Hygiene & Tropical Medicine | Graduate Degree |
| University of Essex | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Sheila M. Grant
